Lidocaine with Epinephrine Injection Shortage

• • Lidocaine (with epinephrine 1:100,000) injection, Pfizer, 1%, 30 mL vial, 25 count, NDC 00409-3178-02
  • Lidocaine (with epinephrine 1:100,000) injection, Pfizer, 1%, 50 mL vial, 25 count, NDC 00409-3178-03
  • Lidocaine (with epinephrine 1:100,000) injection, Pfizer, 2%, 30 mL vial, 25 count, NDC 00409-3182-02
  • Lidocaine (with epinephrine 1:100,000) injection, Pfizer, 2%, 50 mL vial, 25 count, NDC 00409-3182-03
  • Lidocaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 50 mL vial, 25 count, NDC 00409-3177-01
  • Lidocaine (with epinephrine 1:200,000) injection, Pfizer, 1.5%, 30 mL vial, 25 count, NDC 00409-3181-01
  • Lidocaine (with epinephrine 1:200,000) injection, Pfizer, 2%, 20 mL vial, 5 count, NDC 00409-3183-01
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 2%, 10 mL vial, 25 count, NDC 63323-0489-17

• • Fresenius Kabi has Xylocaine with epinephrine presentations available.
  • Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays and increased demand.

• • Lidocaine (with epinephrine 1:100,000) injection, Pfizer, 1%, 20 mL vial, 25 count, NDC 00409-0007-10
  • Lidocaine (with epinephrine 1:100,000) injection, Pfizer, 2%, 20 mL vial, 10 count, NDC 00409-0147-10
  • Lidocaine (with epinephrine 1:200,000) injection, Pfizer, 1.5%, 5 mL glass ampule, 10 count, NDC 00409-1209-01
  • Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.5%, 50 mL vial, 25 count, NDC 63323-0481-57
  • Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 1%, 10 mL vial, 25 count, NDC 63323-0482-17
  • Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 1%, 20 mL vial, 25 count, NDC 63323-0482-27
  • Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 1%, 50 mL vial, 25 count, NDC 63323-0482-57
  • Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 2%, 20 mL vial, 25 count, NDC 63323-0483-27
  • Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 2%, 50 mL vial, 25 count, NDC 63323-0483-57
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 1%, 10 mL vial, 25 count, NDC 63323-0487-17
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 1%, 30 mL vial, sterile-pack 5 count, NDC 63323-0487-31
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 1%, 30 mL vial, 25 count, NDC 63323-0487-37
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 1.5%, 10 mL vial, 25 count, NDC 63323-0488-17
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 1.5%, 30 mL vial, 25 count, NDC 63323-0488-37
  • Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 2%, 20 mL vial, 25 count, NDC 63323-0489-27

Estimated Resupply Dates

• • Pfizer has 0.5% lidocaine (1:200,000) with epinephrine 50 mL vials on back order and the company estimates a release date of June 2025. The 1% lidocaine (1:100,000) with epinephrine 30 mL and 50 mL vials are on back order and the company estimates a release date of January 2026 for the 30 mL vials and June 2025 for the 50 mL vials. The 1.5% lidocaine (1:200,000) with epinephrine 30 mL vials are on back order and the company estimates a release date of June 2025. The 2% lidocaine (1:200,000) with epinephrine 20 mL vials are on back order and the company estimates a release date of June 2025. The 2% lidocaine (1:100,000) with epinephrine 30 mL and 50 mL vials are on back order and the company estimates a release date of June 2025.
  • Fresenius Kabi has short-dated 2% Xylocaine-MPF (1:200,000) with epinephrine available with an expiration date of < 3 months.